LCDC 2 Lung Cancer Discrete Choice Study

  • Research type

    Research Study

  • Full title

    Understanding how ‘lung cancer symptoms’ and ‘service’ factors drive the decision to seek help from a GP in the Scottish public: a discrete choice experiment

  • IRAS ID

    180502

  • Contact name

    David Weller

  • Contact email

    David.Weller@ed.ac.uk

  • Sponsor organisation

    University of Edinburgh

  • Clinicaltrials.gov Identifier

    , 14/SS/1088

  • Duration of Study in the UK

    0 years, 4 months, 1 days

  • Research summary

    This study is based on presenting an I-pad based choice questionnaire to patients registered with a GP in order to understand how they decide to consult their GP for lung cancer symptoms. This is a survey using an electronic questionnaire that will take place in GP practice waiting rooms. Consenting patients will complete the questionnaire on a tablet computer (smaller than a conventional laptop, with touch screen 8"x 6") while they are waiting to see their GP. Patients will be asked to respond to a maximum of 12 choice comparisons, each involving two (or three) choices, since three was the most cognitively acceptable for respondents in the developmental stage. These choices involved hypothetical services and symptoms which might lead them to consult their general pactice.
    The study will have policy relevance; there is currently a great deal of interest in refining techniques which encourage people to present with symptoms and to design health services which are as accommodating and flexible as possible - all with the aim of promoting early diagnosis. Outputs of this research will inform public awareness and general practice based interventions in Scotland.
    After conducting focus groups and cognitive inteviews with GP registered patients recruited from two GP practices in Edinburgh (Lothian) the design has now been finalised. This work was done in order to seek final approval before participants are recruited from GP practices. Those involved in this study will not have a lung cancer diagnosis. The research is funded by Early Diagnosis Advisory Group (Cancer Research UK).

  • REC name

    East of Scotland Research Ethics Service REC 1

  • REC reference

    15/ES/0131

  • Date of REC Opinion

    7 Sep 2015

  • REC opinion

    Further Information Favourable Opinion